Role of exogenous melatonin in skin biology
外源性褪黑激素在皮肤生物学中的作用
基本信息
- 批准号:8476985
- 负责人:
- 金额:$ 31.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAgingAgonistAlgaeAntioxidantsApoptoticAttenuatedBacteriaBehaviorBindingBiochemicalBiologicalBiological Response ModifiersBiologyBuffersCellsChemicalsCircadian RhythmsCosmeticsCutaneousDegradation PathwayDiseaseDissectionDoseEpidermisEukaryotaExhibitsGene SilencingGenomeHomeostasisHormonesHumanHyperpigmentationIn VitroInflammatoryInvertebratesMalignant NeoplasmsMeasuresMediatingMelanogenesisMelatoninMembraneMetabolismMitochondriaMolecularNatureNeurotransmittersNuclearNuclear ReceptorsOxidative StressPathologyPathway interactionsPhenotypePigmentation physiologic functionPineal glandPlantsPrecancerous ConditionsProcessProductionPropertyProteinsQuinone ReductasesRadiation induced damageReactive Oxygen SpeciesReceptor, Melatonin, MT2RegulationRetinaRoleSerotoninSkinSkin AgingSpecificityStressStructureSunscreening AgentsSystemTechnologyTestingTherapeuticTryptophanUV Radiation ExposureUltraviolet B RadiationVertebratesVitiligoautocrinebiological adaptation to stressclinical applicationcytokinekeratinocytemelanocytemelanomamethoxyindolenovel therapeuticsparacrinereceptorskin disorderstressor
项目摘要
DESCRIPTION (provided by applicant): It was assumed that in vertebrates melatonin is only produced in the pineal gland and retina. However, evidence has accumulated that melatonin is widely detectable throughout Nature, being found in vertebrates, invertebrates, plants, unicellular eukaryotes, algae and even bacteria. We have documented that melatonin is produced and metabolized by the mammalian skin, where it can permeate to all cellular compartments including mitochondria. Melatonin (an amphilic methoxyindole) has pleiotropic bioactivities, as neurotransmitter, hormone, cytokine and biological response modifier, which are mediated by interactions with high affinity receptors. Melatonin is also a broad-spectrum antioxidant and acting via receptor-independent manner it activates cytoprotective pathways and at high concentrations it attenuates or counteracts the oxidative stress. These antioxidant effects are also shared by its metabolite, N1-acetyl-N2-formyl-5- methoxykynuramine (AFMK), phylogenetically the oldest product of melatonin metabolism. Thus, melatonin exhibits a number of properties that are extremely useful for the integumental stress-response systems. Accordingly, we have proposed that the cutaneous melatoninergic system enables for cell-specific selectivity through intra-, auto- or paracrine mechanisms, which allow locally counteracting or buffering both environmental and endogenous stressors to maintain skin integrity, independent of circadian pineal melatonin secretion. Such functions should include activation of cytoprotective and anti-apoptotic pathways, and antimutagenic, antigenotoxic and anticancerogenic activites. Melatonin bioactivity would depend on preexistent local degradative pathways and the intensity of exposure to ultraviolet radiation (UVR), e.g., melatonin can be converted non-enzymatically to AFMK through action of reactive oxygen species or UVB. Therefore, we are proposing: 1. To define the protective role of melatonin in human epidermis using epidermal keratinocytes and melanocytes cultured in vitro and human skin explants histocultured ex-vivo; 2. To define the role of melatonin in regulation of melanogenesis; 3. To characterize the pathway of melatonin degradation in cultured human keratinocytes and melanocytes. Realization of these aims will define whether melatonin can be exploited therapeutically, either as a general "skin survival factor" with anti- genotoxic properties or as a "guardian" of genome and cellular integrity. Thus, it may be used as a component of sunscreens or in the treatment of pigmentary diseases (e.g. vitiligo or hyperpigmentation), proliferative processes (including precancerous states, epidermal cancer or even melanoma), UVB-induced pathology, inflammatory dermatoses and skin aging.
描述(由申请人提供):假设脊椎动物中褪黑激素仅在松果体和视网膜中产生。然而,越来越多的证据表明,褪黑激素在自然界中广泛存在,在脊椎动物、无脊椎动物、植物、单细胞真核生物、藻类甚至细菌中都有发现。我们已经证明,褪黑激素是由哺乳动物皮肤产生和代谢的,它可以渗透到包括线粒体在内的所有细胞区室。褪黑素(一种两亲性甲氧基吲哚)具有多效性生物活性,如神经递质、激素、细胞因子和生物反应调节剂,这些生物活性通过与高亲和力受体的相互作用介导。褪黑激素也是一种广谱抗氧化剂,通过不依赖于受体的方式发挥作用,激活细胞保护途径,在高浓度时,它可以减弱或抵消氧化应激。其代谢物 N1-乙酰基-N2-甲酰基-5-甲氧基犬尿胺 (AFMK) 也具有这些抗氧化作用,AFMK 在系统发育上是褪黑素代谢最古老的产物。因此,褪黑激素表现出许多对外皮应激反应系统极其有用的特性。因此,我们提出,皮肤褪黑激素系统能够通过内分泌、自分泌或旁分泌机制实现细胞特异性选择性,从而局部抵消或缓冲环境和内源性应激源,以维持皮肤完整性,而不受昼夜节律松果体褪黑激素分泌的影响。这些功能应包括细胞保护和抗凋亡途径的激活,以及抗突变、抗原毒性和抗癌活性。褪黑激素的生物活性取决于预先存在的局部降解途径和暴露于紫外线辐射 (UVR) 的强度,例如,褪黑激素可以通过活性氧或 UVB 的作用以非酶促方式转化为 AFMK。因此,我们建议: 1. 利用体外培养的表皮角质形成细胞和黑素细胞以及离体组织培养的人皮肤外植体,明确褪黑素对人表皮的保护作用; 2. 明确褪黑激素在黑色素生成调节中的作用; 3. 表征培养的人角质形成细胞和黑素细胞中褪黑激素的降解途径。这些目标的实现将决定褪黑激素是否可以用于治疗,或者作为具有抗基因毒性的一般“皮肤存活因子”,或者作为基因组和细胞完整性的“守护者”。因此,它可以用作防晒霜的成分或用于治疗色素性疾病(例如白癜风或色素沉着过度)、增殖过程(包括癌前状态、表皮癌甚至黑色素瘤)、UVB诱导的病理、炎症性皮肤病和皮肤老化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDRZEJ T SLOMINSKI其他文献
ANDRZEJ T SLOMINSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDRZEJ T SLOMINSKI', 18)}}的其他基金
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancer
CYP11A1 衍生的类固醇作为 UVB 诱导皮肤癌的治疗剂
- 批准号:
10436919 - 财政年份:2019
- 资助金额:
$ 31.64万 - 项目类别:
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancer
CYP11A1 衍生的类固醇作为 UVB 诱导皮肤癌的治疗剂
- 批准号:
10265344 - 财政年份:2019
- 资助金额:
$ 31.64万 - 项目类别:
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancer
CYP11A1 衍生的类固醇作为 UVB 诱导皮肤癌的治疗剂
- 批准号:
10630816 - 财政年份:2019
- 资助金额:
$ 31.64万 - 项目类别:
Mechanism of action and function of novel secosteroid 20(OH)D3 in the skin
新型secosteroid 20(OH)D3在皮肤中的作用机制和功能
- 批准号:
9914825 - 财政年份:2018
- 资助金额:
$ 31.64万 - 项目类别:
Mechanism of action and function of novel secosteroid 20(OH)D3 in the skin
新型secosteroid 20(OH)D3在皮肤中的作用机制和功能
- 批准号:
10401256 - 财政年份:2018
- 资助金额:
$ 31.64万 - 项目类别:
Significance of metabolic activation of lumisterol in the skin
皮肤中光甾醇代谢激活的意义
- 批准号:
10238125 - 财政年份:2017
- 资助金额:
$ 31.64万 - 项目类别:
Significance of metabolic activation of lumisterol in the skin
皮肤中光甾醇代谢激活的意义
- 批准号:
9756150 - 财政年份:2017
- 资助金额:
$ 31.64万 - 项目类别:
Role of Exogenous Melatonin in Skin Biology
外源性褪黑激素在皮肤生物学中的作用
- 批准号:
8874110 - 财政年份:2015
- 资助金额:
$ 31.64万 - 项目类别:
Mechanism of action of 20-hydroxyvitamin D3 in dermal fibroblasts
20-羟基维生素D3对真皮成纤维细胞的作用机制
- 批准号:
9101104 - 财政年份:2015
- 资助金额:
$ 31.64万 - 项目类别:
Mechanism of action of 20-hydroxyvitamin D3 in dermal fibroblasts
20-羟基维生素D3对真皮成纤维细胞的作用机制
- 批准号:
8930444 - 财政年份:2015
- 资助金额:
$ 31.64万 - 项目类别:
相似国自然基金
ALA光动力上调炎症性成纤维细胞ZFP36抑制GADD45B/MAPK通路介导光老化皮肤组织微环境重塑的作用及机制研究
- 批准号:82303993
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
湿热老化下的CFRP胶-螺连接结构疲劳失效机理研究
- 批准号:52305160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
YAP1-TEAD通过转录调控同源重组修复介导皮肤光老化的作用机制
- 批准号:82371567
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
来源和老化过程对大气棕碳光吸收特性及环境气候效应影响的模型研究
- 批准号:42377093
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
角质形成细胞源性外泌体携载miR-31调控成纤维细胞ERK通路抗皮肤老化的作用机制
- 批准号:82373460
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Leucine as a Probe of Kynurenine-Induced Glutamate and Neural Circuit Dysfunction in Midlife Depression
亮氨酸作为犬尿氨酸诱导的谷氨酸和中年抑郁症神经回路功能障碍的探针
- 批准号:
10753154 - 财政年份:2023
- 资助金额:
$ 31.64万 - 项目类别:
Modulating prostaglandin E2 receptor activity to improve pancreatic islet function
调节前列腺素 E2 受体活性以改善胰岛功能
- 批准号:
10611349 - 财政年份:2022
- 资助金额:
$ 31.64万 - 项目类别:
Modulating prostaglandin E2 receptor activity to improve pancreatic islet function
调节前列腺素 E2 受体活性以改善胰岛功能
- 批准号:
10360796 - 财政年份:2022
- 资助金额:
$ 31.64万 - 项目类别:
Age-Associated B Cells Specialized for Immunity to Pathogens?
与年龄相关的 B 细胞专门针对病原体具有免疫能力?
- 批准号:
10218497 - 财政年份:2021
- 资助金额:
$ 31.64万 - 项目类别:
Amyloid-inspired Vaccine Delivery for the Elderly
为老年人提供淀粉样蛋白疫苗
- 批准号:
10300848 - 财政年份:2021
- 资助金额:
$ 31.64万 - 项目类别: